Cocaine abuse in the United States has reached epidemic proportions. The overall objectives of this research are to identify, isolate and determine the molecular properties of cocaine receptors, which mediate cocaine's most relevant central and peripheral pharmacological and toxicological actions, to elucidate their mechanisms of interaction with cocaine and to establish what cocaine addiction does to the densities and affinities of these cocaine receptors, providing clues for possible therapy. Cocaine is taken for its strong central stimulant action, but also has powerful reinforcing and cardiovascular effects, which are reasonably correlated to inhibition of biogenic amine uptake into nerve terminals. Yet other biogenic amine uptake inhibitors (e.g. tricyclic antidepressants) do not have cocaine's stimulant and reinforcing properties. The hypothesis to be tested is that cocaine receptors are associated with amine transporters (i.e. uptake sites), with possibly three subtypes: A dopamine (DA) transporter which mediates its central stimulant action and is abundant in the striatum; a norepinephrine (NE) transporter which mediates the cardiovascular effects and a 5-hydroxytryptamine (5HT) transporter, which contributes to the central actions and is in brain and other tissues.
The specific aims are to identify, purify and investigate the molecular properties of cocaine receptors associated with DA transporter in brain striatum, NE transporter in heart and 5HT transporter in platelets, and verify their identities in reconstituted systems. Also, to synthesize cocaine derivatives suitable for photoaffinity labeling, identification and purification of cocaine receptors and to determine the effects of cocaine addiction and recovery on cocaine and biogenic amine receptors. Identification of the cocaine receptor relies on correlating the potencies of specific drugs in inhibiting 3H- cocaine binding and biogenic amine uptake, as well as reduction of 3H-cocaine binding produced by pretreatment with selective neurotoxins. The cocaine receptor subtypes will be purified by affinity chromatography, and its purity, molecular height and subunit structure determined by gel filtration, sucrose gradient sedimentation and electrophoresis. Reconstitution of 3H-cocaine binding and amine transport function into liposomes containing the isolated protein is the proof for the physiologic identity of the cocaine receptor.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
2R01DA003680-04A1
Application #
3208246
Study Section
Pharmacology I Research Subcommittee (DABR)
Project Start
1985-07-01
Project End
1990-06-30
Budget Start
1988-07-01
Budget End
1989-06-30
Support Year
4
Fiscal Year
1988
Total Cost
Indirect Cost
Name
University of Maryland Baltimore
Department
Type
Schools of Medicine
DUNS #
003255213
City
Baltimore
State
MD
Country
United States
Zip Code
21201
Eshleman, A; Dunigan, C; Shamoo, A et al. (1995) ATP enhances catecholamine uptake into PC12 cells. Life Sci 56:1613-21
Eshleman, A J; Calligaro, D O; Eldefrawi, M E (1993) Allosteric regulation by sodium of the binding of [3H]cocaine and [3H]GBR 12935 to rat and bovine striata. Membr Biochem 10:129-44
el-Maghrabi, E A; Eckenhoff, R G (1993) Inhibition of dopamine transport in rat brain synaptosomes by volatile anesthetics. Anesthesiology 78:750-6
He, X; Raymon, L P; Mattson, M V et al. (1993) Further studies of the structure-activity relationships of 1-[1-(2-benzo[b]thienyl)cyclohexyl]piperidine. Synthesis and evaluation of 1-(2-benzo[b]thienyl)-N,N-dialkylcyclohexylamines at dopamine uptake and phencyclidine binding sites. J Med Chem 36:4075-81
Kline Jr, R H; Wright, J; Eshleman, A J et al. (1991) Synthesis of 3-carbamoylecgonine methyl ester analogues as inhibitors of cocaine binding and dopamine uptake. J Med Chem 34:702-5
Ahmed, M S; Zhou, D H; Maulik, D et al. (1990) Characterization of a cocaine binding protein in human placenta. Life Sci 46:553-61
Kline Jr, R H; Wright, J; Fox, K M et al. (1990) Synthesis of 3-arylecgonine analogues as inhibitors of cocaine binding and dopamine uptake. J Med Chem 33:2024-7
Cao, C J; Shamoo, A E; Eldefrawi, M E (1990) Cocaine-sensitive, ATP-dependent dopamine uptake into striatal synaptosomes. Biochem Pharmacol 39:R9-14
Cao, C J; Eldefrawi, A T; Eldefrawi, M E (1990) ATP-regulated neuronal catecholamine uptake: a new mechanism. Life Sci 47:655-67
Cao, C J; Young, M M; Wong, J B et al. (1989) Putative cocaine receptor in striatum is a glycoprotein with active thiol function. Membr Biochem 8:207-20

Showing the most recent 10 out of 13 publications